Scynexis Europe Ltd
|Fyfield Business & Research Park,
Tel: 0044 (0) 1277 367000
Fax: 0044 (0) 1277 367099
SCYNEXIS provides a full range of highly integrated synthetic chemistry processes and technologies to the life sciences industry - From Concept To Clinic™ - representing the next step in the industrialization of the drug discovery process. By combining its chemists' expertise with its proprietary MEDCHEM-FACTORY™ and HEOS™ technologies, SCYNEXIS works to increase the productivity and speed of the pharmaceutical discovery process. We also offer novel hit generation compounds, hit explosion and lead optimisation services as well as process optimisation, the production of clinical samples in its GMP facility and radiochemistry synthesis services.
Further Information: http://www.scynexis.com
Related news from our archive
Scynexis Extendes the Installation of ACD/Labs NMR Processing Tools
Installation of tools will help to accelerate drug discovery and development at Scynexis' research facility in Research Triangle Park.
Scynexis Europe is now Selcia Following Spin off from Scynexis Inc.
Selcia will offer new services such as metabolomics and metabolic profiling, and their integration with chemistry.